BRPI0821503A2 - Alterações no número de cópias que preveem a capacidade de metástase do câncer de mama em seres humanos - Google Patents

Alterações no número de cópias que preveem a capacidade de metástase do câncer de mama em seres humanos

Info

Publication number
BRPI0821503A2
BRPI0821503A2 BRPI0821503-0A BRPI0821503A BRPI0821503A2 BR PI0821503 A2 BRPI0821503 A2 BR PI0821503A2 BR PI0821503 A BRPI0821503 A BR PI0821503A BR PI0821503 A2 BRPI0821503 A2 BR PI0821503A2
Authority
BR
Brazil
Prior art keywords
humans
changes
breast cancer
copy number
cancer metastasis
Prior art date
Application number
BRPI0821503-0A
Other languages
English (en)
Inventor
Yi Zhang
Jack X Yu
Yuqiu Jiang
Yixin Wang
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of BRPI0821503A2 publication Critical patent/BRPI0821503A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0821503-0A 2007-12-14 2008-12-15 Alterações no número de cópias que preveem a capacidade de metástase do câncer de mama em seres humanos BRPI0821503A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US765007P 2007-12-14 2007-12-14
PCT/US2008/086815 WO2009079450A2 (en) 2007-12-14 2008-12-15 Copy number alterations that predict metastatic capability of human breast cancer

Publications (1)

Publication Number Publication Date
BRPI0821503A2 true BRPI0821503A2 (pt) 2015-06-16

Family

ID=40626665

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821503-0A BRPI0821503A2 (pt) 2007-12-14 2008-12-15 Alterações no número de cópias que preveem a capacidade de metástase do câncer de mama em seres humanos

Country Status (9)

Country Link
US (1) US20090155805A1 (pt)
EP (1) EP2231874A2 (pt)
JP (1) JP2011505840A (pt)
KR (1) KR20100093595A (pt)
CN (1) CN101918591A (pt)
BR (1) BRPI0821503A2 (pt)
CA (1) CA2709395A1 (pt)
IL (1) IL206194A0 (pt)
WO (1) WO2009079450A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
EP3360978A3 (en) 2009-05-07 2018-09-26 Veracyte, Inc. Methods for diagnosis of thyroid conditions
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
CA2785999C (en) * 2009-12-14 2021-04-13 North Carolina State University Mean dna copy number of chromosomal regions is of prognostic significance in cancer
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
EP3068906B1 (en) 2013-11-15 2021-01-06 North Carolina State University Chromosomal assessment to diagnose urogenital malignancy in dogs
US10501806B2 (en) 2014-04-15 2019-12-10 North Carolina State University Chromosomal assessment to differentiate histiocytic malignancy from lymphoma in dogs
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
WO2016014941A1 (en) 2014-07-24 2016-01-28 North Carolina State University Method to diagnose malignant melanoma in the domestic dog
CN104200060A (zh) * 2014-07-30 2014-12-10 福建医科大学附属第一医院 预测巨大肝癌患者术后近期复发转移概率的模型及方法
CN104293943A (zh) * 2014-10-09 2015-01-21 武汉艾迪康医学检验所有限公司 检测Ppm1d基因多态突变位点的引物和方法
US20170335396A1 (en) 2014-11-05 2017-11-23 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
US10961591B2 (en) 2016-05-31 2021-03-30 North Carolina State University Methods of mast cell tumor prognosis and uses thereof
CN106498035A (zh) * 2016-09-30 2017-03-15 厦门飞朔生物技术有限公司 一种用于高通量测序检测化疗药物基因snp变异文库的构建方法及其应用
KR101994821B1 (ko) * 2016-11-23 2019-07-01 연세대학교 산학협력단 포크머리상자 o 3 단백질의 용도
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
WO2019152788A1 (en) * 2018-02-02 2019-08-08 Morgan And Mendel Genomics, Inc. Robust genomic predictor of breast and lung cancer metastasis
CN111467493A (zh) * 2019-01-23 2020-07-31 首都师范大学 人rev3l蛋白切割抑制剂及其应用
GB2595718A (en) * 2020-06-04 2021-12-08 Cancer Research Tech Ltd Methods for predicting treatment response in cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
EP1578994A2 (en) * 2002-11-11 2005-09-28 Affymetrix, Inc. Methods for identifying dna copy number changes
US20050255507A1 (en) * 2004-02-17 2005-11-17 Jenkins Robert B Cytogenetically determined diagnosis and prognosis of proliferative disorders
WO2006128195A2 (en) * 2005-05-27 2006-11-30 Dana-Farber Cancer Institute Methods of diagnosing and treating cancer by detection of chromosomal abnormalities

Also Published As

Publication number Publication date
CN101918591A (zh) 2010-12-15
IL206194A0 (en) 2010-12-30
JP2011505840A (ja) 2011-03-03
KR20100093595A (ko) 2010-08-25
WO2009079450A3 (en) 2009-10-01
EP2231874A2 (en) 2010-09-29
CA2709395A1 (en) 2009-06-25
WO2009079450A2 (en) 2009-06-25
US20090155805A1 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
BRPI0821503A2 (pt) Alterações no número de cópias que preveem a capacidade de metástase do câncer de mama em seres humanos
BRPI0716498A2 (pt) Genes e polipeptídeos relacionados a cânceres de mama
BRPI0809989A2 (pt) antígeno associado com a neovasculatura de metástases tumorais
DK2115472T3 (da) Cancerbiomarkører
EP2203885A4 (en) COMPUTER BASED ENERGY MANAGEMENT
EP2210228A4 (en) MULTIPLE PAYMENT APPLICATIONS COMPREHENSIVE EQUIPMENT
EP2165278A4 (en) LANGUAGE CROSSING INFORMATION REQUEST
EP2069784A4 (en) IL-33 IN INFLAMMATORY DISEASE
BRPI0812765A2 (pt) Antígeno associado a cânceres de pulmão e linfomas
PT2207037T (pt) Método para a deteção de cancro
EP2044551A4 (en) CASCADED SPINE SIMULATION
BRPI0810095A2 (pt) Método para a contagem de células
DE602008001760D1 (de) Bargeldverarbeitungsmaschine
BRPI0813227A2 (pt) Máquinas de processamento para redução de material.
BRPI0718427A2 (pt) Ferramenta informática de gestão de documentos numéricos
BRPI0810783A2 (pt) Dentifrício opaco em múltiplas fases com serpentinas
FR2903515B3 (fr) Ensemble carte memoire
TWI349850B (en) Computer
BRPI0811250A2 (pt) Dentifrício opaco em múltiplas fases com faixas alternadas.
DE102008064410A8 (de) Bearbeitungsmaschine
GB0701752D0 (en) Definitions in master documents
GB2449352B (en) Sluice gate
GB0702689D0 (en) Touchpad
DK2000023T3 (da) Dataopsamlingsanordning
GB0703268D0 (en) Machine document reading

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.